Assessing the nephrotoxicity of intravenous iodinated contrast agents in patients with chronic renal failure in the absence of interfering acute disease.

Authors:
Jaume Almirall
Jaume Almirall
Institut Universitari Parc Taulí
Spain
Marta Andreu
Marta Andreu
Institut Universitari Parc Taulí-UAB
Spain
Elena Gonzalez
Elena Gonzalez
Hospital Universitario La Paz
Spain

Acta Radiol 2019 Apr 18:284185119840764. Epub 2019 Apr 18.

1 Department of Radiology, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Sabadell, Spain.

Background: The existence of contrast-induced nephropathy is widely accepted. Recent studies suggest its incidence has been overestimated.

Purpose: To determine the effect of intravenous iodinated contrast agents on renal function in patients with chronic renal failure without acute disease that can interfere with the assessment of renal function.

Material And Methods: We prospectively analyzed changes in serum creatinine levels after intravenous administration of iodinated contrast agents in all patients with chronic renal failure (creatinine clearance < 60 mL/min by the CKD-EPI Equation) without acute disease referred for computed tomography (CT) follow-up of aortic aneurysm. Between March 2010 and December 2016, a total of 108 patients met the inclusion criteria. The first 35 patients randomly underwent both contrast-enhanced and unenhanced CT examinations six months apart; the 73 following patients underwent only contrast-enhanced CT examinations. Serum creatinine levels were recorded immediately before and 48-72 h after CT examinations. Contrast-induced nephropathy was defined as an increase of ≥25% in serum creatinine from baseline levels.

Results: In the first 35 patients, mean changes in creatinine levels after unenhanced and enhanced CT examinations were similar. From the total of 108 patients who underwent contrast-enhanced CT, serum creatinine increased > 25% with respect to baseline in only two patients, in one case after contrast-enhanced CT examination and in the other after unenhanced CT examination; in a third patient, serum creatinine decreased >25% after contrast-enhanced CT examination.

Conclusion: No relevant contrast-induced nephrotoxicity was detected in this group of patients with chronic renal failure without acute disease.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0284185119840764DOI Listing
April 2019
2 Reads

Publication Analysis

Top Keywords

patients chronic
16
chronic renal
16
renal failure
16
contrast agents
12
iodinated contrast
12
acute disease
12
agents patients
8
failure acute
8
intravenous iodinated
8
serum creatinine
8
renal
6
patients
5
administration iodinated
4
intravenous administration
4
failure creatinine
4
disease interfere
4
respect baseline
4
clearance  25% respect
4
creatinine clearance  25%
4
levels intravenous
4

References

(Supplied by CrossRef)

Similar Publications